Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

This study has been terminated.

( Lack of efficacy with respect to skin-related lesions in the short-term phase )

Study NCT00534313 Information provided by Bristol-Myers Squibb

First Received on September 20, 2007. Last Updated on July 25, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Psoriatic Arthritis

Additional conditions recognized in this trial

Arthritis
Arthritis, Psoriatic

More general conditions related to this trial

Interventions listed in this trial

Abatacept
Placebo

More general drug interventions related to this trial

Sponsors listed in this trial

Bristol-Myers Squibb